Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
venture philanthropy fund
|
| gptkbp:focusesOn |
type 1 diabetes
|
| gptkbp:foundedIn |
2016
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
JDRF T1D Fund
|
| gptkbp:investedIn |
early-stage companies
devices for type 1 diabetes diagnostics for type 1 diabetes therapeutics for type 1 diabetes |
| gptkbp:mission |
accelerate life-changing solutions to treat, prevent, and cure type 1 diabetes
|
| gptkbp:notableInvestment |
gptkb:Semma_Therapeutics
gptkb:ViaCyte gptkb:Syntimmune Provention Bio Abata Therapeutics Abilitech Medical AnTolRx Avotres Bigfoot Biomedical Diabeloop Enthera Epsilogen Glycostem Therapeutics Imcyse ImmunoMolecular Therapeutics Orgenesis Sernova TetraGenetics Zucara Therapeutics |
| gptkbp:parentOrganization |
gptkb:JDRF
|
| gptkbp:website |
https://t1dfund.org/
|
| gptkbp:bfsParent |
gptkb:Forge_Biologics
|
| gptkbp:bfsLayer |
7
|